Among mesenchymal stem cells: For the best therapy after ischemic stroke

Stem Cell Research and Therapy

Volumn 4, Issue 1, 2013, Pages

  Ikegame, Yuka ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOGRAFT; ALLOTRANSPLANTATION; APOPTOSIS; AUTOTRANSPLANTATION; BONE MARROW; BRAIN ISCHEMIA; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; HUMAN; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NEUROPROTECTION; PRIORITY JOURNAL; REVIEW; SYNAPTIC TRANSMISSION; ANIMAL; BIOLOGICAL THERAPY; MESENCHYMAL STROMA CELL; PHYSIOLOGY; PROCEDURES; STROKE; TRANSLATIONAL RESEARCH;

ADIPOSE TISSUE; ANIMALS; CELL- AND TISSUE-BASED THERAPY; HUMANS; MESENCHYMAL STROMAL CELLS; STROKE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84873369088     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt157     Document Type: Review

References (12)

1. Effects of i.v. administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Gutiérrez-Fernández M, Rodríguez-Frutos B, Ramos-Cejudo J, Vallejo-Cremades MT, Fuentes B, Cerdán S, Díez-Tejedor E, Stem Cell Res Ther 2013 4 11 10.1186/scrt159 23356495
2. Stem cells and stroke: opportunities, challenges and strategies. Burns TC, Steinberg GK, Expert Opin Biol Ther 2011 11 447 461 10.1517/14712598.2011. 552883 21323594
3. Marrow stromal cell transplantation in stroke and traumatic brain injury. Li Y, Chopp M, Neurosci Lett 2009 456 120 123 10.1016/j.neulet.2008.03.096 19429146
4. Concise review: adipose-derived stem cells as a novel tool for future regenerative medicine. Mizuno H, Tobita M, Uysal AC, Stem Cells 2012 30 804 810 10.1002/stem.1076 22415904
5. Role of mesenchymal stem cells in neurogenesis and nervous system repair. Maltman DJ, Hardy SA, Przyborski SA, Neurochem Int 2011 59 347 356 21718735
6. Mesenchymal stem cells immunosuppressive properties: is it specific to bone marrow-derived cells? Jorgensen C, Stem Cell Res Ther 2010 1 15 10.1186/scrt15 20529386
7. Mesenchymal stem cells: therapeutic outlook for stroke. Honmou O, Onodera R, Sasaki M, Waxman SG, Kocsis JD, Trends Mol Med 2012 18 292 297 10.1016/j.molmed.2012.02.003 22459358
8. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Ikegame Y, Yamashita K, Hayashi S, Mizuno H, Tawada M, You F, Yamada K, Tanaka Y, Egashira Y, Nakashima S, Yoshimura S, Iwama T, Cytotherapy 2011 13 675 685 10.3109/14653249.2010.549122 21231804
9. Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats. Gutiérrez-Fernández M, Rodríguez-Frutos B, Álvarez-Grech J, Vallejo-Cremades MT, Expósito-Alcaide M, Merino J, Roda JM, Díez-Tejedor E, Neuroscience 2011 175 394 405 21144885
10. Neural differentiation ability of mesenchymal stromal cells from bone marrow and adipose tissue: a comparative study. Zhang HT, Liu ZL, Yao XQ, Yang ZJ, Xu RX, Cytotherapy 2012 14 1203 1214 10.3109/14653249.2012.711470 22909277
11. Differentiation of single cell derived human mesenchymal stem cells into cells with a neuronal phenotype: RNA and microRNA expression profile. Crobu F, Latini V, Marongiu MF, Sogos V, Scintu F, Porcu S, Casu C, Badiali M, Sanna A, Manchinu MF, Ristaldi MS, Mol Biol Rep 2012 39 3995 4007 10.1007/s11033-011- 1180-9 21773948
12. Unique molecular signatures influencing the biological function and fate of post-natal stem cells isolated from different sources. Abu Kasim NH, Govindasamy V, Gnanasegaran N, Musa S, Pradeep PJ, Srijaya TC, Aziz ZA, J Tissue Eng Regen Med 2012 10.1002/term.1663